Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS08 - Industry Symposium Sponsored by Eli Lilly And Company: Personalizing and Optimizing Treatment for Metastatic NSCLC Patients with EGFR Mutations - Is There More We Can Do?

    • 05:45 - 06:45
    • 9/10/2021
    • Location: Industry Symposium Auditorium via Industry Hub
    • Not for CME Credit
    • Type: Industry Supported Symposium
    • Track: N.A.
    • +

      IS08.01 - Welcome and Introduction

      05:45 - 05:50  |  Presenter: Mark A. Socinski

      • Abstract

      No abstract available for this presentation

    • +

      IS08.02 - Is a One Size Fits All Approach Still Appropriate for NSCLC with an EGFR Mutation, Are All Mutations Equal?

      05:50 - 06:05  |  Presenter: Silvia Novello

      • Abstract

      No abstract available for this presentation

    • +

      IS08.03 - Scientific Rationale for Dual Inhibition of VEGF and EGFR

      06:05 - 06:15  |  Presenter: Nobuyuki Takakura

      • Abstract

      No abstract available for this presentation

    • +

      IS08.04 - Identifying the Clinical and Disease Characteristics of the High Risk Patient, What Is the Science Telling Us?

      06:15 - 06:25  |  Presenter: Myung-Ju Ahn

      • Abstract

      No abstract available for this presentation

    • +

      IS08.05 - Panel Discussion and Q&A

      06:25 - 06:40

      • Abstract

      No abstract available for this presentation

    • +

      IS08.06 - Symposium Closing Remarks

      06:40 - 06:45  |  Presenter: Mark A. Socinski

      • Abstract

      No abstract available for this presentation

  • +

    IS09 - Industry Symposium Sponsored by Janssen Pharmaceutical Research & Development: Innovations in Lung Cancer Detection and Management of Non-Small Cell Lung Cancer (NSCLC) With Targeted Therapy

    • 05:45 - 06:45
    • 9/10/2021
    • Location: Industry Symposium Auditorium via Industry Hub
    • Not for CME Credit
    • Type: Industry Supported Symposium
    • Track: N.A.
    • +

      IS09.01 - Welcome and Introductions

      05:45 - 05:50  |  Presenter: Joshua Sabari

      • Abstract

      No abstract available for this presentation

    • +

      IS09.02 - EGFR Mutated NSCLC – Progress, Recent Developments, and Unmet Needs

      05:50 - 06:05  |  Presenter: Ticiana Leal

      • Abstract

      No abstract available for this presentation

    • +

      IS09.03 - Advances in Early Diagnosis, Detection and Intervention of Lung Cancer

      06:05 - 06:20  |  Presenter: Chris Manley

      • Abstract

      No abstract available for this presentation

    • +

      IS09.04 - Discussion & Q&A

      06:20 - 06:45

      • Abstract

      No abstract available for this presentation

  • +

    IS10 - Satellite CME Symposium by Research To Practice: Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer and Validated Targets Beyond EGFR

    • 05:45 - 06:45
    • 9/10/2021
    • Location: Program Auditorium
    • CME Accredited by Other Provider
    • Type: Satellite CME Symposia
    • Track: N.A.
    • +

      IS10.01 - MODULE 1: Selection and Sequencing of Therapy for Patients with Non-Small Cell Lung Cancer (NSCLC) and an ALK Rearrangement

      05:45 - 06:00

      • Abstract

      No abstract available for this presentation

    • +

      IS10.02 - MODULE 2: Current and Future Directions in the Management of ROS1-Positive NSCLC

      06:00 - 06:15

      • Abstract

      No abstract available for this presentation

    • +

      IS10.03 - MODULE 3: Optimal Use of Recently Approved RET Inhibitors in the Care of Patients with RET-Positive NSCLC

      06:15 - 06:30

      • Abstract

      No abstract available for this presentation

    • +

      IS10.04 - MODULE 4: Rational Approaches to Targeting MET Abnormalities for Patients with NSCLC

      06:30 - 06:45

      • Abstract

      No abstract available for this presentation

  • +

    JIES01 - Joint IASLC – ESTRO Session: Advances in Radiotherapy for Lung Cancer

    • 07:00 - 08:00
    • 9/10/2021
    • Location: Program Auditorium
    • Not for CME Credit
    • Type: Education Session
    • Track: N.A.
    • +

      JIES01.01 - RT in Oligometastatic Disease

      07:00 - 07:10  |  Presenter: Fiona Mary Alison McDonald

      • Abstract

      No abstract available for this presentation

    • +

      JIES01.02 - Radiomics and Radiotherapy: State of the Art and Future Challenges

      07:10 - 07:20  |  Presenter: Dirk De Ruysscher

      • Abstract

      Loading...

    • +

      JIES01.03 - Combining Radiotherapy and Immunotherapy

      07:20 - 07:30  |  Presenter: Corinne Faivre-Finn

      • Abstract

      No abstract available for this presentation

    • +

      JIES01.04 - Prophylactic Cranial Irradiation in Lung Cancer: Where We Are

      07:30 - 07:40  |  Presenter: Ben J. Slotman

      • Abstract

      Loading...

    • +

      JIES01.05 - Live Discussion with Speakers

      07:40 - 08:00

      • Abstract

      No abstract available for this presentation

  • +

    ES01 - Proactive Tobacco and Cancer Control*

    • 07:30 - 08:05
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Risk Reduction and Tobacco Control
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES01.01 - The Influence of Lung Cancer Provider in Tobacco Control and Policy Advocacy

      07:30 - 07:32  |  Presenter: Charis Girvalaki

      • Abstract

      No abstract available for this presentation

    • +

      ES01.02 - Setting Clinical Tobacco Cessation Efforts Up for Success

      07:32 - 07:34  |  Presenter: Joelle Thirsk Fathi

      • Abstract

      No abstract available for this presentation

    • +

      ES01.03 - Integration of Cessation Services in Low Dose CT Screening

      07:34 - 07:36  |  Presenter: Emily Stone

      • Abstract

      Loading...

    • +

      ES01.04 - Examining Health Outcomes in Patients Being Treated for Lung Cancer Who Smoke

      07:36 - 07:38  |  Presenter: Matt Evison

      • Abstract

      No abstract available for this presentation

    • +

      ES01.05 - Live Discussion with Speakers

      07:38 - 08:05

      • Abstract

      No abstract available for this presentation

  • +

    ES02 - Multidisciplinary Collaboration in the Treatment of Oligometastatic Disease*

    • 08:15 - 08:50
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Multimodality of Advanced Lung Cancer
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES02.01 - Overview of Oligometastatic Disease

      08:15 - 08:17  |  Presenter: Ross Soo

      • Abstract

      No abstract available for this presentation

    • +

      ES02.02 - Surgical Trials in Oligometastatic Disease

      08:17 - 08:19  |  Presenter: Nasser Altorki

      • Abstract

      No abstract available for this presentation

    • +

      ES02.03 - Radiation Trials in Oligometastatic Disease: Any Actionable Answers?

      08:19 - 08:21  |  Presenter: Puneeth Iyengar

      • Abstract

      No abstract available for this presentation

    • +

      ES02.04 - Systemic Therapy Influenced Trials in Oligometastatic Disease

      08:21 - 08:23  |  Presenter: Paul Leslie Ross Mitchell

      • Abstract

      Loading...

    • +

      ES02.05 - Uncertainties and Controversies in Oligometastatic Disease

      08:23 - 08:25  |  Presenter: Suresh Senan

      • Abstract

      No abstract available for this presentation

    • +

      ES02.06 - Live Discussion with Speakers

      08:25 - 08:50

      • Abstract

      No abstract available for this presentation

  • +

    ES03 - Optimizing Survival with Multidisciplinary Collaboration*

    • 08:15 - 08:50
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Nursing and Allied Health Professionals
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES03.01 - The Effects of Lung Cancer on Patient's Sexual Functioning: Nursing View

      08:15 - 08:17  |  Presenter: Somaya Abou-Abdou

      • Abstract

      No abstract available for this presentation

    • +

      ES03.02 - Speech Pathology Management in Lung Cancer

      08:17 - 08:19  |  Presenter: Jacqui Frowen

      • Abstract

      No abstract available for this presentation

    • +

      ES03.03 - Empowering Patients to Make Change: The Use of Motivational Interviewing

      08:19 - 08:21  |  Presenter: Ashlee Mulimba

      • Abstract

      No abstract available for this presentation

    • +

      ES03.04 - Multimodal Intervention (Nutrition, Exercise, Pharmacological) for Cancer Cachexia in Lung Cancer

      08:21 - 08:23  |  Presenter: Nicole Kiss

      • Abstract

      No abstract available for this presentation

    • +

      ES03.05 - Enhanced Recovery After Thoracic Surgery

      08:23 - 08:25  |  Presenter: TaCharra Woodard

      • Abstract

      No abstract available for this presentation

    • +

      ES03.06 - Live Discussion with Speakers

      08:25 - 08:50

      • Abstract

      No abstract available for this presentation

  • +

    ES04 - Antibody–Drug Conjugates: Current Status and Future Perspectives*

    • 09:00 - 09:35
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Novel Therapeutics and Targeted Therapies
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES04.01 - Structure and Mechanism of Antibody Drug Conjugates

      09:00 - 09:02  |  Presenter: Bob T. Li

      • Abstract

      No abstract available for this presentation

    • +

      ES04.02 - Antibody Drug Conjugates for Non-small Cell Lung Cancer

      09:02 - 09:04  |  Presenter: Hidetoshi Hayashi

      • Abstract

      Loading...

    • +

      ES04.03 - Antibody Drug Conjugates for Other Thoracic Tumor Types

      09:04 - 09:06  |  Presenter: David Planchard

      • Abstract

      No abstract available for this presentation

    • +

      ES04.04 - Antibody Drug Conjugates for Combination Therapy

      09:06 - 09:08  |  Presenter: Byoung Chul Cho

      • Abstract

      No abstract available for this presentation

    • +

      ES04.05 - Live Discussion with Speakers

      09:08 - 09:35

      • Abstract

      No abstract available for this presentation

  • +

    ES05 - A New Era of Treatment and Diagnosis for Mesothelioma and Thymoma*

    • 09:00 - 09:35
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES05.01 - Molecular Markers in Mesothelioma

      09:00 - 09:02  |  Presenter: Jennifer L. Sauter

      • Abstract

      No abstract available for this presentation

    • +

      ES05.02 - Advances in Immunotherapy in Malignant Pleural Mesothelioma

      09:02 - 09:04  |  Presenter: Arnaud Scherpereel

      • Abstract

      No abstract available for this presentation

    • +

      ES05.03 - CAR T-cell Therapy in Mesothelioma and Thymic Cancer

      09:04 - 09:06  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      No abstract available for this presentation

    • +

      ES05.04 - The Latest Updates in Thymoma

      09:06 - 09:08  |  Presenter: Meinoshin Okumura

      • Abstract

      No abstract available for this presentation

    • +

      ES05.05 - Live Discussion with Speakers

      09:08 - 09:35

      • Abstract

      No abstract available for this presentation

  • +

    ES06 - Immuno-Biology and Novel Immunotherapeutics in Lung Cancer*

    • 09:45 - 10:20
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES06.01 - Task Force in Methodology: Developing New Trials with Immunotherapeutic Agents

      09:45 - 09:47  |  Presenter: Rosalyn Juergens

      • Abstract

      No abstract available for this presentation

    • +

      ES06.02 - Bi-Specific Agents

      09:47 - 09:49  |  Presenter: Taofeek Owonikoko

      • Abstract

      No abstract available for this presentation

    • +

      ES06.03 - "Not Just Another irAE" - Identification and Management of Immunotoxicities of Bispecifics and CAR-T

      09:49 - 09:51  |  Presenter: Melissa Johnson

      • Abstract

      No abstract available for this presentation

    • +

      ES06.04 - Intra-tumoral Immunotherapy

      09:51 - 09:53  |  Presenter: Stephane Champiat

      • Abstract

      No abstract available for this presentation

    • +

      ES06.05 - Approach to Chemotherapy for Oncogene-driven Cancers: Known Barriers and Future Promise

      09:53 - 09:55  |  Presenter: Noemi Reguart

      • Abstract

      No abstract available for this presentation

    • +

      ES06.06 - Live Discussion with Speakers

      09:55 - 10:20

      • Abstract

      No abstract available for this presentation